BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Ariad Pharmaceuticals Incorporated

ARIAD Pharmaceuticals, Inc. is focused on the discovery and development of novel and proprietary drugs based on its understanding of the inner-workings of cells and the genes involved in disease. The Company has developed a product based on its gene regulation technology to treat graft-versus-host disease, a complication of bone marrow transplantation involving an attack by a patient's immune system on healthy tissue. This product entered Phase 1 human clinical trials in December 1998. All of the Company's other drug candidates are in the pre-clinical stage as at the end of 1998.


Contact Details:
26 Landsdowne Street
Cambridge
MA
02139-4234
United States of America
Tel:617 494 0400
Fax:617 494 8144
Email:investor@ariad.com
WWW:

www.ariad.com/




Loading...

Recent Publications by Ariad Pharmaceuticals Incorporated:

Novel N9-arenethenyl purines as potent dual Src/Abl tyrosine kinase inhibitors.
Novel N(9)-arenethenyl purines, optimized potent dual Src/Abl tyrosine...
12th August, 2008
ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, MA 02139, Bioorg Med Chem Lett. 2008 Sep 1;18(17):4907-12. Epub 2008 Jun 18.
DOI Direct Link
SAR of carbon-linked, 2-substituted purines: synthesis and characterization of AP23451 as a novel bone-targeted inhibitor of Src tyrosine kinase with in vivo anti-resorptive activity.
Targeted disruption of the pp60(src) (Src) gene has implicated this...
9th April, 2008
ARIAD Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, MA 02139, Chem Biol Drug Des. 2008 Feb;71(2):97-105. Epub 2008 Jan 3.
DOI Direct Link
Determination of protein-DNA sequence specificity by PCR-assisted binding-site selection.
Binding-site selection is used to determine the target specificity of a...
22nd February, 2008
Ariad Pharmaceuticals, Inc., Cambridge, Massachusetts, USA. Curr Protoc Mol Biol. 2001 May;Chapter 12:Unit 12.11.
DOI Direct Link
Crystal structure of the T315I mutant of AbI kinase.
Imatinib (Gleevec) is currently the frontline therapy for chronic myeloid...
20th October, 2007
ARIAD Pharmaceuticals Inc, 26 Landsdowne St., Cambridge, MA 02139, USA. Chem Biol Drug Des. 2007 Sep;70(3):171-81.
DOI Direct Link
Chemical biology and drug design: three-dimensional, dynamic, and mechanistic nature of two multidisciplinary fields.
Protein phosphorylation has been exploited by Nature in profound ways to...
10th March, 2007
Chemical Biology & Drug Design, Drug Discovery, ARIAD Pharmaceuticals, Chem Biol Drug Des. 2006 Mar;67(3):196-200.
DOI Direct Link

View more Ariad Pharmaceuticals Incorporated research publications.

BioNews Results for Ariad Pharmaceuticals Incorporated:

Lehman Bros Changes EPS Estimate of ARIAD PHARMACEUTICALS INC: Current Recommendation is Overweight
Calibre Macro World:  Sep 30 2008 6:52PM Matching: ariad pharmaceuticals
Lehman Bros Changes EPS Estimate of ARIAD PHARMACEUTICALS INC: Current Recommendation is Overweight
Macro World Investor:  Sep 30 2008 6:48PM Matching: ariad pharmaceuticals
Ariad's Patent: A Court Rules
Corante:  Sep 26 2008 10:56AM Matching: ariad pharmaceuticals
Ariad disappointed at patent ruling
IP World Online:  Sep 26 2008 6:06AM Matching: ariad pharmaceuticals
Court Ruling Raises Concerns About Ariad's Conduct and Patents
Seeking Alpha:  Sep 25 2008 10:30AM Matching: ariad pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution

View more Ariad Pharmaceuticals Incorporated news.

Ariad Pharmaceuticals Incorporated Patents:

US Patent No.Title
7238679 Heterocycles and uses thereof
6303319 Cell based assay for identifying sh2-domain-specific signal transducer antagonist
6258823 Materials and method for treating or preventing pathogenic fungal infection
6251620 Three dimensional structure of a ZAP tyrosine protein kinase fragment and modeling methods
6207397 In vitro fluorescence polarization assay

View more Ariad Pharmaceuticals Incorporated patents.

Ariad Pharmaceuticals Incorporated (ARIA) Financial information Links from Barchart

ARIA Quote from from Barchart.com
ARIA Chart from from Barchart.com
ARIA Profile from from Barchart.com
ARIA Opinion from from Barchart.com

View more Ariad Pharmaceuticals Incorporated finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 18 individuals from Ariad Pharmaceuticals Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 215 times since April 2007, the link to the organisation's website has been followed 38 times

Recent Search Terms used to find this page: ARIAD PHARMACEUTICALS | deforolimus-structure | Ariad Pharmaceuticals Inc. | deforolimus structure | .

Search for more companies in Cambridge

Search for more companies in MA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Ariad Pharmaceuticals Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.